BriaCell Therapeutics Corp (BCTX)

[GimmeWater]

Main focus of this early trial is safety, but tumor size will be monitored as well. If previous results are any indication, results in a year or year-and-a-half will be astounding!!!!

"The primary objective of the clinical trial is to evaluate the safety of BriaVax™ in study subjects, and the principal secondary objective is an evaluation of the tumor size reduction. Tumor response will be monitored every three months during the study. The trial will also evaluate progression-free survival (PFS) and overall survival (OS)."